254. Porphyria Clinical trials / Disease details

Clinical trials : 70 / Drugs : 54 - (DrugBank : 19) / Drug target genes : 19 - Drug target pathways : 35

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00004831 (ClinicalTrials.gov)	October 1996	24/2/2000	Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria		Erythropoietic Protoporphyria	Drug: cysteine hydrochloride	FDA Office of Orphan Products Development	St. Luke's-Roosevelt Hospital Center	Completed	18 Years	65 Years	Both	20	N/A	NULL
2	NCT00004940 (ClinicalTrials.gov)	May 1996	24/2/2000	Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria		Erythropoietic Protoporphyria	Drug: cysteine hydrochloride	Brigham and Women's Hospital	NULL	Completed	18 Years	65 Years	Both	50	Phase 3	NULL